
Baird Capital
Description
Baird Capital is a global private equity and venture capital firm with a long-standing history, headquartered in Milwaukee, Wisconsin, and maintaining offices in Chicago, London, and Shanghai. The firm manages over $4.5 billion in capital, deploying it across various stages and geographies through its distinct investment platforms: US Private Equity, UK Private Equity, and Venture Capital. This diversified approach allows Baird Capital to engage with a broad spectrum of companies, from early-stage ventures to established lower middle-market businesses.
The Venture Capital arm of Baird Capital is particularly focused on early-stage and growth-stage companies within the B2B Technology & Services and Healthcare sectors. This team seeks out businesses that have demonstrated proven business models, possess strong management teams, and exhibit significant potential for future growth. Their investment strategy in this segment is geared towards providing substantial capital to fuel expansion and innovation.
For its venture capital investments, Baird Capital typically writes initial checks ranging from $5 million to $20 million. This substantial range allows them to support companies through various growth phases, from Series A to later-stage rounds. The firm's Venture Capital team has a notable track record, having invested over $300 million in more than 50 companies, underscoring their commitment and experience in the venture ecosystem. Beyond capital, Baird Capital emphasizes providing strategic guidance and leveraging its extensive network to support portfolio companies in achieving their objectives.
Investor Profile
Baird Capital has backed more than 178 startups, with 3 new investments in the last 12 months alone. The firm has led 98 rounds, about 55% of its total and boasts 48 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, China.
- Strong thematic focus on Health Care, Medical, Software.
- Led 3 rounds in the past year.
- Typical check size: $5M – $20M.
Stage Focus
- Series B (25%)
- Series C (20%)
- Series A (17%)
- Series Unknown (16%)
- Series D (8%)
- Private Equity (8%)
- Series E (2%)
- Seed (2%)
- Debt Financing (1%)
- Grant (1%)
Country Focus
- United States (87%)
- United Kingdom (7%)
- China (4%)
- Canada (1%)
- Taiwan (1%)
- Malaysia (1%)
Industry Focus
- Health Care
- Medical
- Software
- Biotechnology
- Enterprise Software
- Information Technology
- Saas
- Medical Device
- Analytics
- Human Resources
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.